+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

High-density Multiplexed Diagnostic Assays - Global Market Trajectory & Analytics

  • ID: 5139838
  • Report
  • September 2020
  • Region: Global
  • 175 pages
  • Global Industry Analysts, Inc
Global High-density Multiplexed Diagnostic Assays Market to Reach $3.2 Billion by 2027

Amid the COVID-19 crisis, the global market for High-density Multiplexed Diagnostic Assays estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at a CAGR of 14.4% over the period 2020-2027. High-Density Multiplexed Diagnostic Assays (500-10,000 plex), one of the segments analyzed in the report, is projected to record 14.1% CAGR and reach US$1.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Very High-Density Multiplexed Diagnostic Assays (>10,000 plex) segment is readjusted to a revised 14.9% CAGR for the next 7-year period.

The U. S. Market is Estimated at $363.6 Million, While China is Forecast to Grow at 13.9% CAGR

The High-density Multiplexed Diagnostic Assays market in the U. S. is estimated at US$363.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$551.1 Million by the year 2027 trailing a CAGR of 13.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.8% and 12.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR. We bring years of research experience to this 6th edition of our report. The 175-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Erba Diagnostics, Inc.
  • F. Hoffmann-La Roche AG
  • Gold Standard Diagnostics Corporation
  • Hologic, Inc.
  • Luminex Corporation
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Global Competitor Market Shares
  • High-density Multiplexed Diagnostic Assays Competitor Market Share ScenarioWorldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: High-density Multiplexed Diagnostic Assays Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 2: High-density Multiplexed Diagnostic Assays Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019
  • TABLE 3: High-density Multiplexed Diagnostic Assays Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: High-Density Multiplexed Diagnostic Assays (500-10,000 plex) (Product) World Market by Region/Country in US$ Thousand: 2020 to 2027
  • TABLE 5: High-Density Multiplexed Diagnostic Assays (500-10,000 plex) (Product) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019
  • TABLE 6: High-Density Multiplexed Diagnostic Assays (500-10,000 plex) (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: Very High-Density Multiplexed Diagnostic Assays (>10,000 plex) (Product) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027
  • TABLE 8: Very High-Density Multiplexed Diagnostic Assays (>10,000 plex) (Product) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019
  • TABLE 9: Very High-Density Multiplexed Diagnostic Assays (>10,000 plex) (Product) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: Clinical Diagnostic Laboratories (End-Use) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 11: Clinical Diagnostic Laboratories (End-Use) Retrospective Demand Analysis in US$ Thousand by Region/Country: 2012-2019
  • TABLE 12: Clinical Diagnostic Laboratories (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Hospitals and Clinics (End-Use) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027
  • TABLE 14: Hospitals and Clinics (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019
  • TABLE 15: Hospitals and Clinics (End-Use) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
  • Market Facts & Figures
  • US High-density Multiplexed Diagnostic Assays Market Share (in %) by Company: 2019 & 2025
  • Market Analytics
  • TABLE 16: United States High-density Multiplexed Diagnostic Assays Market Estimates and Projections in US$ Thousand by Product: 2020 to 2027
  • TABLE 17: High-density Multiplexed Diagnostic Assays Market in the United States by Product: A Historic Review in US$ Thousand for 2012-2019
  • TABLE 18: United States High-density Multiplexed Diagnostic Assays Market Share Breakdown by Product: 2012 VS 2020 VS 2027
  • TABLE 19: United States High-density Multiplexed Diagnostic Assays Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 20: High-density Multiplexed Diagnostic Assays Historic Demand Patterns in the United States by End-Use in US$ Thousand for 2012-2019
  • TABLE 21: High-density Multiplexed Diagnostic Assays Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027
CANADA
  • TABLE 22: Canadian High-density Multiplexed Diagnostic Assays Market Estimates and Forecasts in US$ Thousand by Product: 2020 to 2027
  • TABLE 23: Canadian High-density Multiplexed Diagnostic Assays Historic Market Review by Product in US$ Thousand: 2012-2019
  • TABLE 24: High-density Multiplexed Diagnostic Assays Market in Canada: Percentage Share Breakdown of Sales by Product for 2012, 2020, and 2027
  • TABLE 25: Canadian High-density Multiplexed Diagnostic Assays Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 26: High-density Multiplexed Diagnostic Assays Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019
  • TABLE 27: Canadian High-density Multiplexed Diagnostic Assays Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
JAPAN
  • TABLE 28: Japanese Market for High-density Multiplexed Diagnostic Assays: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2020-2027
  • TABLE 29: High-density Multiplexed Diagnostic Assays Market in Japan: Historic Sales Analysis in US$ Thousand by Product for the Period 2012-2019
  • TABLE 30: Japanese High-density Multiplexed Diagnostic Assays Market Share Analysis by Product: 2012 VS 2020 VS 2027
  • TABLE 31: Japanese Demand Estimates and Forecasts for High-density Multiplexed Diagnostic Assays in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 32: Japanese High-density Multiplexed Diagnostic Assays Market in US$ Thousand by End-Use: 2012-2019
  • TABLE 33: High-density Multiplexed Diagnostic Assays Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027
CHINA
  • TABLE 34: Chinese High-density Multiplexed Diagnostic Assays Market Growth Prospects in US$ Thousand by Product for the Period 2020-2027
  • TABLE 35: High-density Multiplexed Diagnostic Assays Historic Market Analysis in China in US$ Thousand by Product: 2012-2019
  • TABLE 36: Chinese High-density Multiplexed Diagnostic Assays Market by Product: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • TABLE 37: Chinese Demand for High-density Multiplexed Diagnostic Assays in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 38: High-density Multiplexed Diagnostic Assays Market Review in China in US$ Thousand by End-Use: 2012-2019
  • TABLE 39: Chinese High-density Multiplexed Diagnostic Assays Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
EUROPE
  • Market Facts & Figures
  • European High-density Multiplexed Diagnostic Assays Market: Competitor Market Share Scenario (in %) for 2019 & 2025
  • Market Analytics
  • TABLE 40: European High-density Multiplexed Diagnostic Assays Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027
  • TABLE 41: High-density Multiplexed Diagnostic Assays Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019
  • TABLE 42: European High-density Multiplexed Diagnostic Assays Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 43: European High-density Multiplexed Diagnostic Assays Market Estimates and Forecasts in US$ Thousand by Product: 2020-2027
  • TABLE 44: High-density Multiplexed Diagnostic Assays Market in Europe in US$ Thousand by Product: A Historic Review for the Period 2012-2019
  • TABLE 45: European High-density Multiplexed Diagnostic Assays Market Share Breakdown by Product: 2012 VS 2020 VS 2027
  • TABLE 46: European High-density Multiplexed Diagnostic Assays Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
  • TABLE 47: High-density Multiplexed Diagnostic Assays Market in Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019
  • TABLE 48: European High-density Multiplexed Diagnostic Assays Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
FRANCE
  • TABLE 49: High-density Multiplexed Diagnostic Assays Market in France by Product: Estimates and Projections in US$ Thousand for the Period 2020-2027
  • TABLE 50: French High-density Multiplexed Diagnostic Assays Historic Market Scenario in US$ Thousand by Product: 2012-2019
  • TABLE 51: French High-density Multiplexed Diagnostic Assays Market Share Analysis by Product: 2012 VS 2020 VS 2027
  • TABLE 52: High-density Multiplexed Diagnostic Assays Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2020-2027
  • TABLE 53: French High-density Multiplexed Diagnostic Assays Historic Market Review in US$ Thousand by End-Use: 2012-2019
  • TABLE 54: French High-density Multiplexed Diagnostic Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
GERMANY
  • TABLE 55: High-density Multiplexed Diagnostic Assays Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2020-2027
  • TABLE 56: German High-density Multiplexed Diagnostic Assays Historic Market Analysis in US$ Thousand by Product: 2012-2019
  • TABLE 57: German High-density Multiplexed Diagnostic Assays Market Share Breakdown by Product: 2012 VS 2020 VS 2027
  • TABLE 58: High-density Multiplexed Diagnostic Assays Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027
  • TABLE 59: German High-density Multiplexed Diagnostic Assays Market in Retrospect in US$ Thousand by End-Use: 2012-2019
  • TABLE 60: High-density Multiplexed Diagnostic Assays Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027
ITALY
  • TABLE 61: Italian High-density Multiplexed Diagnostic Assays Market Growth Prospects in US$ Thousand by Product for the Period 2020-2027
  • TABLE 62: High-density Multiplexed Diagnostic Assays Historic Market Analysis in Italy in US$ Thousand by Product: 2012-2019
  • TABLE 63: Italian High-density Multiplexed Diagnostic Assays Market by Product: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • TABLE 64: Italian Demand for High-density Multiplexed Diagnostic Assays in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 65: High-density Multiplexed Diagnostic Assays Market Review in Italy in US$ Thousand by End-Use: 2012-2019
  • TABLE 66: Italian High-density Multiplexed Diagnostic Assays Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
UNITED KINGDOM
  • TABLE 67: United Kingdom Market for High-density Multiplexed Diagnostic Assays: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2020-2027
  • TABLE 68: High-density Multiplexed Diagnostic Assays Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Product for the Period 2012-2019
  • TABLE 69: United Kingdom High-density Multiplexed Diagnostic Assays Market Share Analysis by Product: 2012 VS 2020 VS 2027
  • TABLE 70: United Kingdom Demand Estimates and Forecasts for High-density Multiplexed Diagnostic Assays in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 71: United Kingdom High-density Multiplexed Diagnostic Assays Market in US$ Thousand by End-Use: 2012-2019
  • TABLE 72: High-density Multiplexed Diagnostic Assays Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027
REST OF EUROPE
  • TABLE 73: Rest of Europe High-density Multiplexed Diagnostic Assays Market Estimates and Forecasts in US$ Thousand by Product: 2020-2027
  • TABLE 74: High-density Multiplexed Diagnostic Assays Market in Rest of Europe in US$ Thousand by Product: A Historic Review for the Period 2012-2019
  • TABLE 75: Rest of Europe High-density Multiplexed Diagnostic Assays Market Share Breakdown by Product: 2012 VS 2020 VS 2027
  • TABLE 76: Rest of Europe High-density Multiplexed Diagnostic Assays Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
  • TABLE 77: High-density Multiplexed Diagnostic Assays Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019
  • TABLE 78: Rest of Europe High-density Multiplexed Diagnostic Assays Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
ASIA-PACIFIC
  • TABLE 79: High-density Multiplexed Diagnostic Assays Market in Asia-Pacific by Product: Estimates and Projections in US$ Thousand for the Period 2020-2027
  • TABLE 80: Asia-Pacific High-density Multiplexed Diagnostic Assays Historic Market Scenario in US$ Thousand by Product: 2012-2019
  • TABLE 81: Asia-Pacific High-density Multiplexed Diagnostic Assays Market Share Analysis by Product: 2012 VS 2020 VS 2027
  • TABLE 82: High-density Multiplexed Diagnostic Assays Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2020-2027
  • TABLE 83: Asia-Pacific High-density Multiplexed Diagnostic Assays Historic Market Review in US$ Thousand by End-Use: 2012-2019
  • TABLE 84: Asia-Pacific High-density Multiplexed Diagnostic Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
REST OF WORLD
  • TABLE 85: Rest of World High-density Multiplexed Diagnostic Assays Market Estimates and Forecasts in US$ Thousand by Product: 2020 to 2027
  • TABLE 86: Rest of World High-density Multiplexed Diagnostic Assays Historic Market Review by Product in US$ Thousand: 2012-2019
  • TABLE 87: High-density Multiplexed Diagnostic Assays Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2012, 2020, and 2027
  • TABLE 88: Rest of World High-density Multiplexed Diagnostic Assays Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 89: High-density Multiplexed Diagnostic Assays Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019
  • TABLE 90: Rest of World High-density Multiplexed Diagnostic Assays Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
IV. COMPETITION
  • Total Companies Profiled: 46
Note: Product cover images may vary from those shown
Adroll
adroll